Autologous TAC T Cells Targeting CD19 in R/R Large B-Cell Lymphoma
Condition: Lymphoma, B-Cell Intervention: Biological: TAC01-CD19 Sponsor: Triumvira Immunologics, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials